nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC4—Methotrexate—psoriasis	0.0292	0.257	CbGbCtD
Dipyridamole—ABCB1—Mycophenolate mofetil—psoriasis	0.0141	0.124	CbGbCtD
Dipyridamole—ABCB1—Betamethasone—psoriasis	0.0121	0.107	CbGbCtD
Dipyridamole—ABCB1—Prednisolone—psoriasis	0.0119	0.105	CbGbCtD
Dipyridamole—ABCB1—Hydrocortisone—psoriasis	0.0113	0.0999	CbGbCtD
Dipyridamole—ABCB1—Prednisone—psoriasis	0.0113	0.0995	CbGbCtD
Dipyridamole—ABCB1—Cyclosporine—psoriasis	0.0107	0.0943	CbGbCtD
Dipyridamole—ABCB1—Dexamethasone—psoriasis	0.00704	0.0621	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—psoriasis	0.00566	0.0499	CbGbCtD
Dipyridamole—PDE5A—endothelium—psoriasis	0.000398	0.136	CbGeAlD
Dipyridamole—PRUNE—tendon—psoriasis	0.000384	0.132	CbGeAlD
Dipyridamole—Oedema—Triamcinolone—psoriasis	0.000383	0.000585	CcSEcCtD
Dipyridamole—Vertigo—Betamethasone—psoriasis	0.000383	0.000584	CcSEcCtD
Dipyridamole—Vertigo—Dexamethasone—psoriasis	0.000383	0.000584	CcSEcCtD
Dipyridamole—Syncope—Betamethasone—psoriasis	0.000382	0.000583	CcSEcCtD
Dipyridamole—Syncope—Dexamethasone—psoriasis	0.000382	0.000583	CcSEcCtD
Dipyridamole—Pain—Mycophenolate mofetil—psoriasis	0.000382	0.000583	CcSEcCtD
Dipyridamole—Arrhythmia—Prednisone—psoriasis	0.000381	0.000581	CcSEcCtD
Dipyridamole—Hypotension—Hydrocortisone—psoriasis	0.00038	0.000581	CcSEcCtD
Dipyridamole—Feeling abnormal—Cyclosporine—psoriasis	0.000377	0.000576	CcSEcCtD
Dipyridamole—Shock—Triamcinolone—psoriasis	0.000377	0.000576	CcSEcCtD
Dipyridamole—Alopecia—Prednisone—psoriasis	0.000377	0.000575	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Cyclosporine—psoriasis	0.000375	0.000572	CcSEcCtD
Dipyridamole—Loss of consciousness—Betamethasone—psoriasis	0.000375	0.000572	CcSEcCtD
Dipyridamole—Loss of consciousness—Dexamethasone—psoriasis	0.000375	0.000572	CcSEcCtD
Dipyridamole—Dizziness—Mycophenolic acid—psoriasis	0.000374	0.000571	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisolone—psoriasis	0.000374	0.000571	CcSEcCtD
Dipyridamole—Tachycardia—Triamcinolone—psoriasis	0.000374	0.000571	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000371	0.000566	CcSEcCtD
Dipyridamole—Hyperhidrosis—Triamcinolone—psoriasis	0.000371	0.000566	CcSEcCtD
Dipyridamole—Convulsion—Dexamethasone—psoriasis	0.000369	0.000564	CcSEcCtD
Dipyridamole—Convulsion—Betamethasone—psoriasis	0.000369	0.000564	CcSEcCtD
Dipyridamole—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000368	0.000562	CcSEcCtD
Dipyridamole—Hypertension—Dexamethasone—psoriasis	0.000368	0.000562	CcSEcCtD
Dipyridamole—Hypertension—Betamethasone—psoriasis	0.000368	0.000562	CcSEcCtD
Dipyridamole—Paraesthesia—Hydrocortisone—psoriasis	0.000366	0.000558	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000365	0.000558	CcSEcCtD
Dipyridamole—Urticaria—Cyclosporine—psoriasis	0.000364	0.000555	CcSEcCtD
Dipyridamole—Myalgia—Betamethasone—psoriasis	0.000363	0.000554	CcSEcCtD
Dipyridamole—Myalgia—Dexamethasone—psoriasis	0.000363	0.000554	CcSEcCtD
Dipyridamole—Abdominal pain—Cyclosporine—psoriasis	0.000362	0.000553	CcSEcCtD
Dipyridamole—Anxiety—Betamethasone—psoriasis	0.000362	0.000552	CcSEcCtD
Dipyridamole—Anxiety—Dexamethasone—psoriasis	0.000362	0.000552	CcSEcCtD
Dipyridamole—Vomiting—Mycophenolic acid—psoriasis	0.00036	0.000549	CcSEcCtD
Dipyridamole—Discomfort—Betamethasone—psoriasis	0.000358	0.000547	CcSEcCtD
Dipyridamole—Discomfort—Dexamethasone—psoriasis	0.000358	0.000547	CcSEcCtD
Dipyridamole—Dyspepsia—Hydrocortisone—psoriasis	0.000358	0.000547	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—psoriasis	0.000358	0.000547	CcSEcCtD
Dipyridamole—Rash—Mycophenolic acid—psoriasis	0.000357	0.000545	CcSEcCtD
Dipyridamole—Dermatitis—Mycophenolic acid—psoriasis	0.000357	0.000544	CcSEcCtD
Dipyridamole—Pain—Prednisolone—psoriasis	0.000356	0.000544	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—psoriasis	0.000356	0.000544	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—psoriasis	0.000356	0.000544	CcSEcCtD
Dipyridamole—Urticaria—Mycophenolate mofetil—psoriasis	0.000355	0.000542	CcSEcCtD
Dipyridamole—Headache—Mycophenolic acid—psoriasis	0.000355	0.000541	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—psoriasis	0.000354	0.00054	CcSEcCtD
Dipyridamole—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000353	0.000539	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000351	0.000536	CcSEcCtD
Dipyridamole—Fatigue—Hydrocortisone—psoriasis	0.000351	0.000536	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000349	0.000533	CcSEcCtD
Dipyridamole—Pain—Hydrocortisone—psoriasis	0.000348	0.000531	CcSEcCtD
Dipyridamole—Oedema—Betamethasone—psoriasis	0.000348	0.000531	CcSEcCtD
Dipyridamole—Anaphylactic shock—Dexamethasone—psoriasis	0.000348	0.000531	CcSEcCtD
Dipyridamole—Anaphylactic shock—Betamethasone—psoriasis	0.000348	0.000531	CcSEcCtD
Dipyridamole—Oedema—Dexamethasone—psoriasis	0.000348	0.000531	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisone—psoriasis	0.000344	0.000526	CcSEcCtD
Dipyridamole—Paraesthesia—Triamcinolone—psoriasis	0.000344	0.000525	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisolone—psoriasis	0.000344	0.000524	CcSEcCtD
Dipyridamole—Anaemia—Prednisone—psoriasis	0.000343	0.000523	CcSEcCtD
Dipyridamole—Shock—Dexamethasone—psoriasis	0.000342	0.000522	CcSEcCtD
Dipyridamole—Shock—Betamethasone—psoriasis	0.000342	0.000522	CcSEcCtD
Dipyridamole—Dyspnoea—Triamcinolone—psoriasis	0.000342	0.000522	CcSEcCtD
Dipyridamole—Nervous system disorder—Dexamethasone—psoriasis	0.000341	0.000521	CcSEcCtD
Dipyridamole—Nervous system disorder—Betamethasone—psoriasis	0.000341	0.000521	CcSEcCtD
Dipyridamole—Thrombocytopenia—Betamethasone—psoriasis	0.000341	0.00052	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dexamethasone—psoriasis	0.000341	0.00052	CcSEcCtD
Dipyridamole—PDE11A—tendon—psoriasis	0.00034	0.116	CbGeAlD
Dipyridamole—Tachycardia—Betamethasone—psoriasis	0.000339	0.000518	CcSEcCtD
Dipyridamole—Tachycardia—Dexamethasone—psoriasis	0.000339	0.000518	CcSEcCtD
Dipyridamole—Angioedema—Prednisone—psoriasis	0.000339	0.000518	CcSEcCtD
Dipyridamole—Hypersensitivity—Cyclosporine—psoriasis	0.000338	0.000515	CcSEcCtD
Dipyridamole—Dyspepsia—Triamcinolone—psoriasis	0.000337	0.000515	CcSEcCtD
Dipyridamole—Nausea—Mycophenolic acid—psoriasis	0.000336	0.000513	CcSEcCtD
Dipyridamole—Hyperhidrosis—Dexamethasone—psoriasis	0.000336	0.000513	CcSEcCtD
Dipyridamole—Hyperhidrosis—Betamethasone—psoriasis	0.000336	0.000513	CcSEcCtD
Dipyridamole—Feeling abnormal—Hydrocortisone—psoriasis	0.000335	0.000512	CcSEcCtD
Dipyridamole—Malaise—Prednisone—psoriasis	0.000335	0.000511	CcSEcCtD
Dipyridamole—Vertigo—Prednisone—psoriasis	0.000333	0.000509	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000333	0.000508	CcSEcCtD
Dipyridamole—Syncope—Prednisone—psoriasis	0.000333	0.000508	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—psoriasis	0.000332	0.000507	CcSEcCtD
Dipyridamole—Urticaria—Prednisolone—psoriasis	0.000331	0.000505	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—psoriasis	0.000331	0.000505	CcSEcCtD
Dipyridamole—Fatigue—Triamcinolone—psoriasis	0.00033	0.000504	CcSEcCtD
Dipyridamole—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000329	0.000502	CcSEcCtD
Dipyridamole—Asthenia—Cyclosporine—psoriasis	0.000329	0.000502	CcSEcCtD
Dipyridamole—Pain—Triamcinolone—psoriasis	0.000328	0.0005	CcSEcCtD
Dipyridamole—Loss of consciousness—Prednisone—psoriasis	0.000326	0.000498	CcSEcCtD
Dipyridamole—Hypotension—Dexamethasone—psoriasis	0.000325	0.000496	CcSEcCtD
Dipyridamole—Hypotension—Betamethasone—psoriasis	0.000325	0.000496	CcSEcCtD
Dipyridamole—Pruritus—Cyclosporine—psoriasis	0.000324	0.000495	CcSEcCtD
Dipyridamole—Urticaria—Hydrocortisone—psoriasis	0.000323	0.000494	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—psoriasis	0.000323	0.000493	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—psoriasis	0.000322	0.000491	CcSEcCtD
Dipyridamole—Abdominal pain—Hydrocortisone—psoriasis	0.000322	0.000491	CcSEcCtD
Dipyridamole—Convulsion—Prednisone—psoriasis	0.000322	0.000491	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—psoriasis	0.000321	0.00049	CcSEcCtD
Dipyridamole—Asthenia—Mycophenolate mofetil—psoriasis	0.000321	0.000489	CcSEcCtD
Dipyridamole—Hypertension—Prednisone—psoriasis	0.00032	0.000489	CcSEcCtD
Dipyridamole—Chills—Methotrexate—psoriasis	0.00032	0.000488	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000317	0.000484	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000317	0.000484	CcSEcCtD
Dipyridamole—Pruritus—Mycophenolate mofetil—psoriasis	0.000316	0.000482	CcSEcCtD
Dipyridamole—Arthralgia—Prednisone—psoriasis	0.000316	0.000482	CcSEcCtD
Dipyridamole—Myalgia—Prednisone—psoriasis	0.000316	0.000482	CcSEcCtD
Dipyridamole—Feeling abnormal—Triamcinolone—psoriasis	0.000316	0.000482	CcSEcCtD
Dipyridamole—Anxiety—Prednisone—psoriasis	0.000315	0.000481	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—psoriasis	0.000315	0.000481	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000314	0.000479	CcSEcCtD
Dipyridamole—Diarrhoea—Cyclosporine—psoriasis	0.000313	0.000478	CcSEcCtD
Dipyridamole—Paraesthesia—Dexamethasone—psoriasis	0.000312	0.000477	CcSEcCtD
Dipyridamole—Paraesthesia—Betamethasone—psoriasis	0.000312	0.000477	CcSEcCtD
Dipyridamole—Discomfort—Prednisone—psoriasis	0.000312	0.000476	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisolone—psoriasis	0.000307	0.000469	CcSEcCtD
Dipyridamole—Dyspepsia—Dexamethasone—psoriasis	0.000306	0.000467	CcSEcCtD
Dipyridamole—Dyspepsia—Betamethasone—psoriasis	0.000306	0.000467	CcSEcCtD
Dipyridamole—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000306	0.000467	CcSEcCtD
Dipyridamole—Urticaria—Triamcinolone—psoriasis	0.000305	0.000465	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—psoriasis	0.000304	0.000464	CcSEcCtD
Dipyridamole—Dizziness—Cyclosporine—psoriasis	0.000303	0.000462	CcSEcCtD
Dipyridamole—Oedema—Prednisone—psoriasis	0.000303	0.000462	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisone—psoriasis	0.000303	0.000462	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Dexamethasone—psoriasis	0.0003	0.000458	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Betamethasone—psoriasis	0.0003	0.000458	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—psoriasis	0.0003	0.000458	CcSEcCtD
Dipyridamole—Hypersensitivity—Hydrocortisone—psoriasis	0.0003	0.000458	CcSEcCtD
Dipyridamole—Fatigue—Betamethasone—psoriasis	0.0003	0.000458	CcSEcCtD
Dipyridamole—Fatigue—Dexamethasone—psoriasis	0.0003	0.000458	CcSEcCtD
Dipyridamole—Shock—Prednisone—psoriasis	0.000298	0.000455	CcSEcCtD
Dipyridamole—Pain—Dexamethasone—psoriasis	0.000297	0.000454	CcSEcCtD
Dipyridamole—Pain—Betamethasone—psoriasis	0.000297	0.000454	CcSEcCtD
Dipyridamole—Nervous system disorder—Prednisone—psoriasis	0.000297	0.000453	CcSEcCtD
Dipyridamole—Tachycardia—Prednisone—psoriasis	0.000296	0.000451	CcSEcCtD
Dipyridamole—Dizziness—Mycophenolate mofetil—psoriasis	0.000296	0.000451	CcSEcCtD
Dipyridamole—Skin disorder—Prednisone—psoriasis	0.000294	0.000449	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisone—psoriasis	0.000293	0.000447	CcSEcCtD
Dipyridamole—Asthenia—Hydrocortisone—psoriasis	0.000292	0.000446	CcSEcCtD
Dipyridamole—Vomiting—Cyclosporine—psoriasis	0.000291	0.000444	CcSEcCtD
Dipyridamole—Rash—Cyclosporine—psoriasis	0.000289	0.000441	CcSEcCtD
Dipyridamole—Dermatitis—Cyclosporine—psoriasis	0.000289	0.00044	CcSEcCtD
Dipyridamole—Pruritus—Hydrocortisone—psoriasis	0.000288	0.00044	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—psoriasis	0.000288	0.000439	CcSEcCtD
Dipyridamole—Headache—Cyclosporine—psoriasis	0.000287	0.000438	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—psoriasis	0.000287	0.000438	CcSEcCtD
Dipyridamole—Feeling abnormal—Betamethasone—psoriasis	0.000287	0.000437	CcSEcCtD
Dipyridamole—Feeling abnormal—Dexamethasone—psoriasis	0.000287	0.000437	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dexamethasone—psoriasis	0.000284	0.000434	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Betamethasone—psoriasis	0.000284	0.000434	CcSEcCtD
Dipyridamole—Vomiting—Mycophenolate mofetil—psoriasis	0.000284	0.000434	CcSEcCtD
Dipyridamole—Hypersensitivity—Triamcinolone—psoriasis	0.000282	0.000431	CcSEcCtD
Dipyridamole—Rash—Mycophenolate mofetil—psoriasis	0.000282	0.00043	CcSEcCtD
Dipyridamole—Dermatitis—Mycophenolate mofetil—psoriasis	0.000281	0.00043	CcSEcCtD
Dipyridamole—Headache—Mycophenolate mofetil—psoriasis	0.00028	0.000427	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—psoriasis	0.00028	0.000427	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—psoriasis	0.000279	0.000425	CcSEcCtD
Dipyridamole—Diarrhoea—Hydrocortisone—psoriasis	0.000279	0.000425	CcSEcCtD
Dipyridamole—Urticaria—Dexamethasone—psoriasis	0.000276	0.000422	CcSEcCtD
Dipyridamole—Urticaria—Betamethasone—psoriasis	0.000276	0.000422	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Prednisone—psoriasis	0.000276	0.000421	CcSEcCtD
Dipyridamole—Dizziness—Prednisolone—psoriasis	0.000276	0.000421	CcSEcCtD
Dipyridamole—Asthenia—Triamcinolone—psoriasis	0.000275	0.00042	CcSEcCtD
Dipyridamole—Abdominal pain—Dexamethasone—psoriasis	0.000275	0.00042	CcSEcCtD
Dipyridamole—Abdominal pain—Betamethasone—psoriasis	0.000275	0.00042	CcSEcCtD
Dipyridamole—Nausea—Cyclosporine—psoriasis	0.000272	0.000415	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisone—psoriasis	0.000272	0.000415	CcSEcCtD
Dipyridamole—Pruritus—Triamcinolone—psoriasis	0.000271	0.000414	CcSEcCtD
Dipyridamole—Cough—Methotrexate—psoriasis	0.000271	0.000413	CcSEcCtD
Dipyridamole—Dizziness—Hydrocortisone—psoriasis	0.000269	0.000411	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—psoriasis	0.000269	0.00041	CcSEcCtD
Dipyridamole—Dyspepsia—Prednisone—psoriasis	0.000267	0.000407	CcSEcCtD
Dipyridamole—Nausea—Mycophenolate mofetil—psoriasis	0.000265	0.000405	CcSEcCtD
Dipyridamole—PDE7B—tendon—psoriasis	0.000265	0.0906	CbGeAlD
Dipyridamole—Chest pain—Methotrexate—psoriasis	0.000264	0.000403	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—psoriasis	0.000264	0.000403	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—psoriasis	0.000264	0.000403	CcSEcCtD
Dipyridamole—Rash—Prednisolone—psoriasis	0.000263	0.000401	CcSEcCtD
Dipyridamole—Dermatitis—Prednisolone—psoriasis	0.000263	0.000401	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000262	0.0004	CcSEcCtD
Dipyridamole—Fatigue—Prednisone—psoriasis	0.000261	0.000399	CcSEcCtD
Dipyridamole—Headache—Prednisolone—psoriasis	0.000261	0.000399	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—psoriasis	0.000261	0.000398	CcSEcCtD
Dipyridamole—Vomiting—Hydrocortisone—psoriasis	0.000259	0.000395	CcSEcCtD
Dipyridamole—Rash—Hydrocortisone—psoriasis	0.000257	0.000392	CcSEcCtD
Dipyridamole—Dermatitis—Hydrocortisone—psoriasis	0.000256	0.000391	CcSEcCtD
Dipyridamole—Headache—Hydrocortisone—psoriasis	0.000255	0.000389	CcSEcCtD
Dipyridamole—Dizziness—Triamcinolone—psoriasis	0.000253	0.000387	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—psoriasis	0.000253	0.000386	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisone—psoriasis	0.00025	0.000381	CcSEcCtD
Dipyridamole—Asthenia—Dexamethasone—psoriasis	0.00025	0.000381	CcSEcCtD
Dipyridamole—Asthenia—Betamethasone—psoriasis	0.00025	0.000381	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—psoriasis	0.000248	0.000379	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—psoriasis	0.000248	0.000378	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Prednisone—psoriasis	0.000248	0.000378	CcSEcCtD
Dipyridamole—Nausea—Prednisolone—psoriasis	0.000248	0.000378	CcSEcCtD
Dipyridamole—Pruritus—Dexamethasone—psoriasis	0.000246	0.000376	CcSEcCtD
Dipyridamole—Pruritus—Betamethasone—psoriasis	0.000246	0.000376	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—psoriasis	0.000246	0.000375	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—psoriasis	0.000245	0.000373	CcSEcCtD
Dipyridamole—Vomiting—Triamcinolone—psoriasis	0.000244	0.000372	CcSEcCtD
Dipyridamole—Nausea—Hydrocortisone—psoriasis	0.000242	0.000369	CcSEcCtD
Dipyridamole—Rash—Triamcinolone—psoriasis	0.000242	0.000369	CcSEcCtD
Dipyridamole—Dermatitis—Triamcinolone—psoriasis	0.000241	0.000369	CcSEcCtD
Dipyridamole—Urticaria—Prednisone—psoriasis	0.000241	0.000367	CcSEcCtD
Dipyridamole—Headache—Triamcinolone—psoriasis	0.00024	0.000366	CcSEcCtD
Dipyridamole—Abdominal pain—Prednisone—psoriasis	0.000239	0.000365	CcSEcCtD
Dipyridamole—Diarrhoea—Betamethasone—psoriasis	0.000238	0.000363	CcSEcCtD
Dipyridamole—Diarrhoea—Dexamethasone—psoriasis	0.000238	0.000363	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—psoriasis	0.000237	0.000361	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000231	0.000352	CcSEcCtD
Dipyridamole—Dizziness—Dexamethasone—psoriasis	0.00023	0.000351	CcSEcCtD
Dipyridamole—Dizziness—Betamethasone—psoriasis	0.00023	0.000351	CcSEcCtD
Dipyridamole—Nausea—Triamcinolone—psoriasis	0.000228	0.000347	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—psoriasis	0.000227	0.000347	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—psoriasis	0.000226	0.000344	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—psoriasis	0.000225	0.000343	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisone—psoriasis	0.000223	0.000341	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—psoriasis	0.000223	0.00034	CcSEcCtD
Dipyridamole—Vomiting—Dexamethasone—psoriasis	0.000221	0.000337	CcSEcCtD
Dipyridamole—Vomiting—Betamethasone—psoriasis	0.000221	0.000337	CcSEcCtD
Dipyridamole—PDE10A—tendon—psoriasis	0.000221	0.0756	CbGeAlD
Dipyridamole—PDE2A—tendon—psoriasis	0.000221	0.0756	CbGeAlD
Dipyridamole—Rash—Betamethasone—psoriasis	0.000219	0.000335	CcSEcCtD
Dipyridamole—Rash—Dexamethasone—psoriasis	0.000219	0.000335	CcSEcCtD
Dipyridamole—Dermatitis—Dexamethasone—psoriasis	0.000219	0.000334	CcSEcCtD
Dipyridamole—Dermatitis—Betamethasone—psoriasis	0.000219	0.000334	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—psoriasis	0.000219	0.000334	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—psoriasis	0.000218	0.000333	CcSEcCtD
Dipyridamole—Headache—Betamethasone—psoriasis	0.000218	0.000333	CcSEcCtD
Dipyridamole—Headache—Dexamethasone—psoriasis	0.000218	0.000333	CcSEcCtD
Dipyridamole—Asthenia—Prednisone—psoriasis	0.000217	0.000332	CcSEcCtD
Dipyridamole—Pain—Methotrexate—psoriasis	0.000216	0.00033	CcSEcCtD
Dipyridamole—Pruritus—Prednisone—psoriasis	0.000214	0.000327	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—psoriasis	0.000209	0.000318	CcSEcCtD
Dipyridamole—Diarrhoea—Prednisone—psoriasis	0.000207	0.000316	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—psoriasis	0.000207	0.000316	CcSEcCtD
Dipyridamole—Nausea—Dexamethasone—psoriasis	0.000207	0.000315	CcSEcCtD
Dipyridamole—Nausea—Betamethasone—psoriasis	0.000207	0.000315	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—psoriasis	0.000201	0.000307	CcSEcCtD
Dipyridamole—Dizziness—Prednisone—psoriasis	0.0002	0.000306	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—psoriasis	0.0002	0.000305	CcSEcCtD
Dipyridamole—Vomiting—Prednisone—psoriasis	0.000193	0.000294	CcSEcCtD
Dipyridamole—Rash—Prednisone—psoriasis	0.000191	0.000291	CcSEcCtD
Dipyridamole—Dermatitis—Prednisone—psoriasis	0.000191	0.000291	CcSEcCtD
Dipyridamole—Headache—Prednisone—psoriasis	0.00019	0.00029	CcSEcCtD
Dipyridamole—PDE8A—tendon—psoriasis	0.000189	0.0649	CbGeAlD
Dipyridamole—Hypersensitivity—Methotrexate—psoriasis	0.000187	0.000285	CcSEcCtD
Dipyridamole—PDE1A—tendon—psoriasis	0.000183	0.0628	CbGeAlD
Dipyridamole—Asthenia—Methotrexate—psoriasis	0.000182	0.000277	CcSEcCtD
Dipyridamole—Nausea—Prednisone—psoriasis	0.00018	0.000275	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—psoriasis	0.000179	0.000273	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—psoriasis	0.000173	0.000264	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—psoriasis	0.000167	0.000255	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—psoriasis	0.000161	0.000246	CcSEcCtD
Dipyridamole—Rash—Methotrexate—psoriasis	0.00016	0.000244	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—psoriasis	0.000159	0.000243	CcSEcCtD
Dipyridamole—Headache—Methotrexate—psoriasis	0.000159	0.000242	CcSEcCtD
Dipyridamole—ADA—tendon—psoriasis	0.000156	0.0534	CbGeAlD
Dipyridamole—Nausea—Methotrexate—psoriasis	0.00015	0.000229	CcSEcCtD
Dipyridamole—PDE5A—tendon—psoriasis	0.000129	0.0443	CbGeAlD
Dipyridamole—PDE3A—tendon—psoriasis	0.000126	0.0431	CbGeAlD
Dipyridamole—ABCC5—tendon—psoriasis	0.000118	0.0405	CbGeAlD
Dipyridamole—SLC29A1—tendon—psoriasis	0.000108	0.0372	CbGeAlD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	9.08e-05	0.000397	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—APOE—psoriasis	9.07e-05	0.000397	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—JUN—psoriasis	9.04e-05	0.000396	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-B—psoriasis	9.02e-05	0.000395	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CXCL8—psoriasis	8.95e-05	0.000392	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CXCL8—psoriasis	8.95e-05	0.000392	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—VEGFA—psoriasis	8.78e-05	0.000384	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—IL6—psoriasis	8.76e-05	0.000384	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CXCL8—psoriasis	8.72e-05	0.000382	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SOCS1—psoriasis	8.72e-05	0.000382	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CRP—psoriasis	8.71e-05	0.000381	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—NFKB1—psoriasis	8.71e-05	0.000381	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—STAT3—psoriasis	8.55e-05	0.000374	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—VEGFA—psoriasis	8.55e-05	0.000374	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—VEGFA—psoriasis	8.55e-05	0.000374	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TYK2—psoriasis	8.52e-05	0.000373	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TYK2—psoriasis	8.52e-05	0.000373	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—IL6—psoriasis	8.51e-05	0.000373	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—IL6—psoriasis	8.51e-05	0.000373	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—CAT—psoriasis	8.49e-05	0.000371	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	8.49e-05	0.000371	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—STAT3—psoriasis	8.47e-05	0.000371	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—STAT3—psoriasis	8.47e-05	0.000371	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—IL6—psoriasis	8.45e-05	0.00037	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—IL6—psoriasis	8.45e-05	0.00037	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HLA-A—psoriasis	8.43e-05	0.000369	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HLA-A—psoriasis	8.43e-05	0.000369	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-A—psoriasis	8.35e-05	0.000366	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-DRB1—psoriasis	8.34e-05	0.000365	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—JUN—psoriasis	8.32e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—JUN—psoriasis	8.32e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—TYK2—psoriasis	8.32e-05	0.000364	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—IL6—psoriasis	8.3e-05	0.000363	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—JUN—psoriasis	8.27e-05	0.000362	CbGpPWpGaD
Dipyridamole—ABCC4—tendon—psoriasis	8.19e-05	0.0281	CbGeAlD
Dipyridamole—PDE4A—Signaling Pathways—SOCS1—psoriasis	8.17e-05	0.000358	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—JUN—psoriasis	8.11e-05	0.000355	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	8.1e-05	0.000354	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—VEGFA—psoriasis	8.03e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—NFKB1—psoriasis	8.01e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—NFKB1—psoriasis	8.01e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ICAM1—psoriasis	8.01e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CXCL8—psoriasis	7.98e-05	0.000349	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CXCL8—psoriasis	7.98e-05	0.000349	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CRP—psoriasis	7.97e-05	0.000349	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—NFKB1—psoriasis	7.96e-05	0.000349	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NFKBIA—psoriasis	7.95e-05	0.000348	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SOCS1—psoriasis	7.95e-05	0.000348	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PPARG—psoriasis	7.9e-05	0.000346	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TYK2—psoriasis	7.9e-05	0.000346	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—STAT3—psoriasis	7.9e-05	0.000346	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—APOE—psoriasis	7.87e-05	0.000345	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—APOE—psoriasis	7.87e-05	0.000345	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—NFKB1—psoriasis	7.81e-05	0.000342	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TYK2—psoriasis	7.79e-05	0.000341	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—STAT3—psoriasis	7.79e-05	0.000341	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—TYK2—psoriasis	7.79e-05	0.000341	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2S1—psoriasis	7.76e-05	0.00034	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—psoriasis	7.74e-05	0.000339	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HLA-A—psoriasis	7.71e-05	0.000338	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-DRB1—psoriasis	7.63e-05	0.000334	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TYK2—psoriasis	7.59e-05	0.000332	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL6—psoriasis	7.59e-05	0.000332	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—TYK2—psoriasis	7.58e-05	0.000332	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SOCS1—psoriasis	7.47e-05	0.000327	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CXCL8—psoriasis	7.47e-05	0.000327	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CXCL8—psoriasis	7.42e-05	0.000325	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CXCL8—psoriasis	7.42e-05	0.000325	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—JUN—psoriasis	7.42e-05	0.000325	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS2—psoriasis	7.34e-05	0.000321	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS2—psoriasis	7.34e-05	0.000321	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ICAM1—psoriasis	7.33e-05	0.000321	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—VEGFA—psoriasis	7.27e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—VEGFA—psoriasis	7.27e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NFKBIA—psoriasis	7.27e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CXCL8—psoriasis	7.26e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CXCL8—psoriasis	7.24e-05	0.000317	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—APOE—psoriasis	7.2e-05	0.000315	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—STAT3—psoriasis	7.2e-05	0.000315	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—STAT3—psoriasis	7.2e-05	0.000315	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—NFKB1—psoriasis	7.14e-05	0.000313	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—TYK2—psoriasis	7.12e-05	0.000312	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—VEGFA—psoriasis	7.09e-05	0.00031	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—psoriasis	7.05e-05	0.000309	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—psoriasis	7.05e-05	0.000309	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—psoriasis	7.05e-05	0.000309	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—STAT3—psoriasis	7.02e-05	0.000307	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—JUN—psoriasis	6.9e-05	0.000302	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—JUN—psoriasis	6.9e-05	0.000302	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CXCL8—psoriasis	6.88e-05	0.000301	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SOCS1—psoriasis	6.83e-05	0.000299	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CXCL8—psoriasis	6.83e-05	0.000299	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CXCL8—psoriasis	6.78e-05	0.000297	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CXCL8—psoriasis	6.78e-05	0.000297	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS2—psoriasis	6.71e-05	0.000294	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—NFKB1—psoriasis	6.64e-05	0.000291	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—NFKB1—psoriasis	6.64e-05	0.000291	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—psoriasis	6.63e-05	0.00029	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CXCL8—psoriasis	6.61e-05	0.000289	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CXCL8—psoriasis	6.6e-05	0.000289	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—APOE—psoriasis	6.59e-05	0.000289	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—psoriasis	6.54e-05	0.000286	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—TYK2—psoriasis	6.51e-05	0.000285	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—TYK2—psoriasis	6.51e-05	0.000285	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—VEGFA—psoriasis	6.48e-05	0.000284	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—psoriasis	6.46e-05	0.000283	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—psoriasis	6.46e-05	0.000283	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—APOE—psoriasis	6.44e-05	0.000282	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—LEP—psoriasis	6.44e-05	0.000282	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—STAT3—psoriasis	6.42e-05	0.000281	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—JUN—psoriasis	6.39e-05	0.00028	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—JUN—psoriasis	6.31e-05	0.000276	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—psoriasis	6.29e-05	0.000275	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CXCL8—psoriasis	6.25e-05	0.000273	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CXCL8—psoriasis	6.2e-05	0.000271	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NFKB1—psoriasis	6.15e-05	0.000269	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—JUN—psoriasis	6.15e-05	0.000269	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNG—psoriasis	6.09e-05	0.000267	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—VEGFA—psoriasis	6.08e-05	0.000266	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NFKB1—psoriasis	6.07e-05	0.000266	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—psoriasis	6.07e-05	0.000266	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—LEP—psoriasis	6.03e-05	0.000264	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—APOE—psoriasis	6.03e-05	0.000264	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VEGFA—psoriasis	6.02e-05	0.000264	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VEGFA—psoriasis	6.02e-05	0.000264	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.02e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TYK2—psoriasis	6.01e-05	0.000263	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TYK2—psoriasis	6.01e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NFKBIA—psoriasis	6e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—psoriasis	5.98e-05	0.000262	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—STAT3—psoriasis	5.97e-05	0.000261	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—STAT3—psoriasis	5.97e-05	0.000261	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TYK2—psoriasis	5.95e-05	0.000261	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NFKB1—psoriasis	5.92e-05	0.000259	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—psoriasis	5.91e-05	0.000259	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—psoriasis	5.91e-05	0.000259	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—psoriasis	5.89e-05	0.000258	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—LEP—psoriasis	5.86e-05	0.000257	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—APOE—psoriasis	5.86e-05	0.000257	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.79e-05	0.000254	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PPARG—psoriasis	5.74e-05	0.000251	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCL8—psoriasis	5.67e-05	0.000248	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NFKBIA—psoriasis	5.62e-05	0.000246	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—psoriasis	5.59e-05	0.000245	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNG—psoriasis	5.57e-05	0.000244	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—STAT3—psoriasis	5.53e-05	0.000242	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—psoriasis	5.52e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—LEP—psoriasis	5.51e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APOE—psoriasis	5.51e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—psoriasis	5.51e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TYK2—psoriasis	5.5e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—psoriasis	5.49e-05	0.00024	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—psoriasis	5.49e-05	0.00024	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—psoriasis	5.47e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NFKBIA—psoriasis	5.46e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—STAT3—psoriasis	5.46e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—psoriasis	5.44e-05	0.000238	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—psoriasis	5.43e-05	0.000238	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—psoriasis	5.43e-05	0.000238	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—psoriasis	5.38e-05	0.000236	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—psoriasis	5.37e-05	0.000235	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—psoriasis	5.35e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—STAT3—psoriasis	5.32e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—JUN—psoriasis	5.27e-05	0.000231	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.26e-05	0.00023	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NFKBIA—psoriasis	5.14e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NFKB1—psoriasis	5.07e-05	0.000222	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—LEP—psoriasis	5.04e-05	0.000221	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOE—psoriasis	5.04e-05	0.000221	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—psoriasis	5.03e-05	0.00022	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—psoriasis	5.03e-05	0.00022	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—psoriasis	5e-05	0.000219	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—psoriasis	4.97e-05	0.000218	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TYK2—psoriasis	4.91e-05	0.000215	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—psoriasis	4.9e-05	0.000215	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—psoriasis	4.9e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—JUN—psoriasis	4.82e-05	0.000211	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NFKBIA—psoriasis	4.7e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NFKB1—psoriasis	4.64e-05	0.000203	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TYK2—psoriasis	4.6e-05	0.000201	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—psoriasis	4.6e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—psoriasis	4.56e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—psoriasis	4.55e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—psoriasis	4.55e-05	0.000199	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.51e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—psoriasis	4.48e-05	0.000196	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TYK2—psoriasis	4.48e-05	0.000196	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL8—psoriasis	4.28e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—psoriasis	4.22e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TYK2—psoriasis	4.21e-05	0.000184	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—psoriasis	4.21e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—psoriasis	4.21e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—psoriasis	4.17e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—psoriasis	4.17e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—psoriasis	4.17e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—psoriasis	4.16e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—psoriasis	4.07e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—psoriasis	4.06e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—psoriasis	4.01e-05	0.000175	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—JUN—psoriasis	3.98e-05	0.000174	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.97e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—psoriasis	3.9e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—psoriasis	3.86e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TYK2—psoriasis	3.85e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—psoriasis	3.85e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NFKB1—psoriasis	3.83e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—psoriasis	3.81e-05	0.000167	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—psoriasis	3.81e-05	0.000167	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CARM1—psoriasis	3.79e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JUN—psoriasis	3.72e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—psoriasis	3.71e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—psoriasis	3.71e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—psoriasis	3.66e-05	0.00016	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JUN—psoriasis	3.62e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NFKB1—psoriasis	3.58e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NFKB1—psoriasis	3.49e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—psoriasis	3.48e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—psoriasis	3.47e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—psoriasis	3.44e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JUN—psoriasis	3.41e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—psoriasis	3.35e-05	0.000147	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NFKB1—psoriasis	3.28e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—psoriasis	3.25e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—psoriasis	3.22e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—psoriasis	3.19e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—psoriasis	3.18e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—psoriasis	3.16e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—psoriasis	3.13e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JUN—psoriasis	3.12e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NFKB1—psoriasis	3e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—psoriasis	2.98e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—psoriasis	2.95e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—psoriasis	2.94e-05	0.000129	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—psoriasis	2.94e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—psoriasis	2.91e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—psoriasis	2.72e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—psoriasis	2.69e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—psoriasis	2.69e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—psoriasis	2.63e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—psoriasis	2.46e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—psoriasis	2.4e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—psoriasis	2.39e-05	0.000105	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAT—psoriasis	2.33e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—psoriasis	2.25e-05	9.85e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—psoriasis	2.25e-05	9.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—psoriasis	2.19e-05	9.58e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—psoriasis	2.06e-05	9.01e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—psoriasis	2.06e-05	9e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—psoriasis	1.88e-05	8.24e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOE—psoriasis	1.81e-05	7.93e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—psoriasis	1.58e-05	6.91e-05	CbGpPWpGaD
